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SUMMARY
Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) is caused by loss-of-function mutations in 
SEIPIN, a protein implicated in both adipogenesis and lipid droplet expansion but whose 
molecular function remains obscure. Here, we identify physical and functional interactions 
between SEIPIN and microsomal isoforms of glycerol-3-phosphate acyltransferase (GPAT) in 
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multiple organisms. Compared to controls, GPAT activity was elevated in SEIPIN-deficient cells 
and tissues and GPAT kinetic values were altered. Increased GPAT activity appears to underpin the 
block in adipogenesis and abnormal lipid droplet morphology associated with SEIPIN loss. Over-
expression of Gpat3 blocked adipogenesis, and Gpat3 knockdown in SEIPIN-deficient 
preadipocytes partially restored differentiation. GPAT overexpression in yeast, preadipocytes, and 
fly salivary glands also formed supersized lipid droplets. Finally, pharmacological inhibition of 
GPAT in Seipin−/− mouse preadipocytes partially restored adipogenesis. These data identify 
SEIPIN as an evolutionarily conserved regulator of microsomal GPAT and suggest that GPAT 
inhibitors might be useful for the treatment of human BSCL2 patients.
In Brief
Pagac et al. find that SEIPIN, which has been linked to Berardinelli-Seip congenital lipodystrophy 
2, interacts with microsomal glycerol-3-phosphate acyltransferase (GPAT) and influences its 
activity. Increased GPAT activity appears to underlie the block in adipogenesis and abnormal lipid 
droplet morphology associated with SEIPIN loss.
INTRODUCTION
Congenital generalized lipodystrophy (CGL; also known as Berardinelli-Seip congenital 
lipodystrophy [BSCL]) is an autosomal recessive disorder characterized by a near total loss 
of adipose tissue, severe hypertriglyceridemia, insulin resistance, and fatty liver (Agarwal 
and Garg, 2006; Magré et al., 2001). To date, four genes have been linked to CGL/BSCL: 1-
acylglycerol-3-phosphate-O-acyltransferase-2 (AGPAT2)/CGL1, SEIPIN/CGL2, 
CAVEOLIN-1/CGL3, and CAVIN-1/CGL4 (Fei et al., 2011a). The most severe form of 
human CGL/BSCL is caused by loss-of-function mutations in SEIPIN/BSCL2, which 
encodes an integral membrane protein of the endoplasmic reticulum (ER) with no 
recognizable functional domains (Fei et al., 2011a; Cartwright and Goodman, 2012; Lundin 
et al., 2006). Seipin knockout (Bscl2−/−) mice have severe lipodystrophy and insulin 
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resistance (Cui et al., 2011; Chen et al., 2012; Prieur et al., 2013), demonstrating an essential 
role for Seipin in adipogenesis. SEIPIN and its non-mammalian orthologs also control the 
expansion of lipid droplets (LDs). The most prominent feature of Seipin-deficient cells is the 
formation of “supersized” LDs (Fei et al., 2008, 2011b; Szymanski et al., 2007; Tian et al., 
2011; Jiang et al., 2014; Liu et al., 2014). Thus, SEIPIN has a unique role in regulating both 
systemic (adipogenesis) and cellular (LD expansion) lipid storage.
Recent studies implicate SEIPIN and its yeast ortholog, Fld1 (also known as Sei1), in 
regulating phospholipid metabolism such that the amount of phosphatidic acid (PA) is 
increased in SEIPIN-deficient cells and tissues (Fei et al., 2011c; Sim et al., 2012; Jiang et 
al., 2014; Wolinski et al., 2015; Han et al., 2015). We have postulated that in preadipocytes, 
increased PA acts as a peroxisome proliferator-activated receptor gamma (PPARγ) 
antagonist and thus blocks adipogenesis (Stapleton et al., 2011; Fei et al., 2011a). In non-
preadipocytes and yeast, PA promotes LD expansion, likely because it is fusogenic (Fei et 
al., 2011c). However, exactly how the ER-localized SEIPIN might regulate the metabolism 
of phospholipids and PA remains unknown.
Through affinity isolation and tandem mass spectrometry analyses, we identified proteins 
that specifically co-precipitate with Fld1-GFP in the yeast Saccharomyces cerevisiae. The 
most prominent of these proteins was Gat1, a glycerol-3-phosphate acyltransferase (GPAT). 
As the rate-limiting step in the synthesis of triacylglycerol and glycerophospholipids, GPAT 
catalyzes the esterification of glycerol-3-phosphate with a long-chain acyl-coenzyme A 
(acetyl-CoA) to initiate the formation of PA (Cao et al., 2012; Marr et al., 2012; Wendel et 
al., 2009). We found that mammalian SEIPIN specifically interacted with the corresponding 
mammalian GPAT orthologs, GPAT3 and GPAT4. SEIPIN deficiency in yeast, mammalian 
cells, and mouse tissues resulted in increased GPAT activity and changes in GPAT kinetics. 
These data strongly suggest that SEIPIN is an evolutionarily conserved regulator of GPAT 
and that targeting GPAT may have therapeutic potential in treating BSCL2.
RESULTS
Fld1 and Gat1 Physically Interact
To identify potential Fld1/SEIPIN-interacting proteins, we used the native promoter of 
FLD1 on a low-copy plasmid in wild-type or fld1Δ yeast cells to express GFP alone or a 
functional Fld1-GFP fusion protein (Fei et al., 2008). Cell membranes were isolated and 
solubilized using three different buffer conditions, followed by affinity purification and 
tandem mass spectrometry analyses (see Experimental Procedures).
In all three buffer/lysis conditions used, 19 proteins co-precipitated with Fld1-GFP, but not 
with matrix or GFP alone (Figure S1A; Table S1). Because our previous studies strongly 
suggested that Fld1/SEIPIN regulates cellular PA content (Fei et al., 2011c; Tian et al., 2011; 
Jiang et al., 2014), we focused on the yeast GPAT, Gat1, which catalyzes the rate-limiting 
step in the de novo synthesis PA and all glycerolipids. Tagged and overexpressed Fld1 and 
Gat1 were co-immunoprecipitated from yeast (Figure 1A), and this interaction was retained 
when both proteins were expressed at close to endogenous levels by adding tags at the C 
termini of their respective genomic loci (Figure 1B). As recently reported (Wang et al., 
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2014), we also identified Ldb16 as an Fld1-interacting protein in our screen (Figure S1A; 
Table S1), and endogenous Ldb16 co-immunoprecipitated with both Fld1-FLAG (Figure 
1B) and Gat1 (Figure 1C). Furthermore, Fld1 and Ldb16 also co-immunoprecipitated with 
Gat2, a second yeast GPAT that shares ~38% sequence identity and ~58% sequence 
similarity with Gat1 (Figures 1C and S1B). However, a yeast AGPAT homolog, Slc4, did not 
co-immunoprecipitate with Fld1 as well as Gat1/2 (Figure 1C). Fld1-Gat1/2 interaction was 
not affected in ldb16 null cells (Figure 1C), but we were not able to test whether the Ldb16 
and Gat1/2 interaction requires Fld1, because Ldb16 is extremely unstable in the absence of 
Fld1 (Wang et al., 2014; data not shown).
Mammalian SEIPIN and GPAT3/4 Physically Interact
Mammals express four GPAT isoforms; GPAT1 and GPAT2 are present on the outer 
mitochondrial membrane, and GPAT3 and GPAT4 are present on the ER (Coleman and 
Mashek, 2011). GPAT1 is resistant to N-ethylmaleimide (NEM), whereas the other GPATs 
are sensitive to NEM. SEIPIN co-immunoprecipitated with both GPAT3 and GPAT4 in 
3T3L1 preadipocytes (Figure 2A). The interaction was significantly weakened (by ~50%) 
between GPAT3/4 and the SEIPIN missense mutant (T78A) that causes a human 
lipodystrophy (Sim et al., 2013) (Figures 2B and 2C, lane 3; Figures S1D and S1E). The C-
terminal cytoplasmic region of SEIPIN was not essential for the interaction with GPAT3 or 
GPAT4, because SEIPIN C-terminal truncation mutants could still co-precipitate a 
significant amount of GPAT3/4 (Figure S1C). Importantly, overexpressed SEIPIN 
immunoprecipitated endogenous GPAT3/4 (the commercial antibody recognizes both 
GPAT3 and GPAT4) (Figure 2D). As an alternative approach, in mature adipocytes, we 
expressed SEIPIN that was fused to the promiscuous biotin ligase BirA* (Roux et al., 2012). 
After affinity purification with streptavidin-conjugated beads, GPAT3/4 was detected only in 
cells expressing SEIPIN-BirA*, but not SEIPIN or BirA* alone (Figure 2E). These data 
indicate that GPAT3/4 in adipocytes lies in close proximity to SEIPIN. Finally, we employed 
a proximity ligation assay to further examine the SEIPIN-GPAT3/4 interaction in vivo 
(Söderberg et al., 2006). GPAT3 and GPAT4 are closer to SEIPIN than AGPAT2 (Figure 
S2A) and, consistent with Figure S1C, full-length SEIPIN, but not its C terminus, interacted 
strongly with GPAT3/4 (Figures S2B and S2C). To examine the effects of SEIPIN on 
GPAT3/4 localization, 3T3-L1 preadipocytes were co-transfected with mCherry-SEIPIN or 
small hairpin RNA (shRNA) targeting SEIPIN and GFP-tagged mouse GPAT3 or GPAT4 
and treated with fatty acids. GPAT3 primarily localizes to LDs, and SEIPIN overexpression 
or knockdown had little effect on GPAT3 localization (Figures S3A, S3B, and S3D). GPAT4 
localizes to both ER and LDs, and SEIPIN knockdown increased the proportion of GPAT4 
on LDs (Figures S3C, S3E, and S3F).
GPAT Activity Is Increased in SEIPIN-Deficient Cells and Tissues
To test whether SEIPIN interacts with GPAT to regulate its activity, we measured GPAT 
activity in control and SEIPIN-deficient yeast cells, mammalian cells, and mouse testes. In 
the absence of SEIPIN, the protein expression of the microsomal GPAT isoforms was 
virtually unchanged (Figures S4A–S4C). However, GPAT-specific activity in fld1 null yeast 
cells was ~60% higher than in controls (Figure 3A). In Seipin−/− mouse embryonic 
fibroblasts (MEFs), the total and microsomal GPAT activities were twice as high as in 
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control MEFs (Figures 3B and S4C). Similarly, when Seipin was knocked down by ~70% in 
3T3L1 preadipocytes, GPAT activity was twice as high as in control preadipocytes (Figures 
3C, S4D, and S4E), and in mouse testes, where Seipin is normally highly expressed, total, 
NEM-sensitive (GPAT2, 3&4) and NEM-resistant (GPAT1) GPAT activities were 67%, 75%, 
and 29% higher, respectively, in Bscl2−/− testes than in controls (Figures 3D and S4F). 
Taken together, these data demonstrate that SEIPIN downregulates GPAT activity and that 
this regulatory role is conserved from yeast to mammals.
SEIPIN-Deficient Cells and Tissues Had Altered GPAT Kinetics
Next, we investigated GPAT enzyme kinetics by characterizing the affinity of GPAT for its 
substrates, glycerol-3-phosphate (glycerol-3-P) and long-chain acyl-CoA. Because acyl-
CoAs are amphipathic and may act as detergents to disrupt membranes and inhibit enzyme 
activity (Polokoff and Bell, 1978), the apparent KM values for acyl-CoAs often cannot be 
accurately calculated. In the absence of SEIPIN, the affinity of GPAT for glycerol-3-P or 
palmitoyl-coenzyme A (palmitoyl-CoA) was altered in MEFs, 3T3L1 cells (Figures 3E–3H 
and S4G–S4J), yeast, and Bscl2−/− mouse testis (Figures S4K–S4N). In each case, GPAT-
specific activity and Vmax increased (Table S2).
Increased GPAT Activity Underpins the Change in LD Morphology in SEIPIN-Deficient Cells
The above data indicate that SEIPIN interacts with GPAT to inhibit its activity. Although the 
immediate product of GPAT catalysis is lysophosphatidic acid, GPAT is the rate-limiting 
step, and the next enzyme in this synthetic pathway, lysophosphatidic acyltransferase, 
rapidly converts lysophosphatidic acid (LPA) to PA. Thus, increasing GPAT activity 
increases the level of PA in mammalian cells (Zhang et al., 2012a, 2014). In yeast, elevated 
PA in the ER is associated with the formation of “supersized” LDs in fld1 null cells (Fei et 
al., 2011c), which had higher GPAT activity (Figures 3 and S4G–S4J). Is the increase in 
GPAT activity sufficient to raise the amount of PA on the ER and drive the formation of 
supersized LDs? Indeed, overexpressing wild-type, but not “catalytically dead,” GAT1 and 
GAT2 in yeast cells caused supersized LDs to form (Figures 4A and S5A), phenocopying 
fld1 null cells. The level of PA in the ER was higher in these cells, similar to fld1 null cells, 
as indicated by increased INO1 expression (Figure S5B) (Loewen et al., 2004). As detected 
by mass spectrometry, overexpression of GAT2 increased microsomal PA (Figure 4B). 
Importantly, when either GAT1 or GAT2 was co-expressed with FLD1, the amount of PA in 
the ER was reduced and few supersized LDs were detected (Figures 4A, 4B, and S5B). 
These results suggest that loss of Fld1 increases GPAT activity and the level of PA in the ER, 
causing the formation of supersized LDs.
Supersized LDs are also present in SEIPIN-deficient mature adipocytes and testes, tissues in 
which SEIPIN is normally highly expressed (Jiang et al., 2014; Liu et al., 2014). 
Overexpressing both GPAT3 and GPAT4 in 3T3-L1 preadipocytes increased microsomal PA 
and formed enlarged LDs (Figures 4C–4E and S5C), but as in yeast, overexpressing SEIPIN 
together with GPAT3 and GPAT4 reduced LD size and microsomal PA (Figures 4C–4E). 
Moreover, knocking down Seipin/Bscl2 in 3T3 L1 preadipocytes increased the size of LDs, 
a feature that was reversed by knocking down either Gpat3 or Gpat4 (Figures S5D and S5E). 
In Huh7 cells, where there is little SEIPIN expression, over-expressing GPAT3 or GPAT4 
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alone can dramatically increase LD size (Figure S5F). To further investigate the functional 
relationship between SEIPIN and GPAT at system level, we examined the morphology of the 
larval salivary gland of Drosophila. Numerous globular structures are present in dSeipin 
mutants (Figure 5A) (Tian et al., 2011), and these structures can be encircled by a lipid 
droplet surface marker PLIN1-mCherry (Figure 5B), indicating that they are lipid droplets. 
GPAT (Drosophila gene CG5508) overexpression results in large lipid droplets similar to 
dSeipin mutants (Figure 5C), while overexpressing AGPAT (CG17608), Lipin (CG8709), or 
DGAT (CG31991) using the same promoter leads to many tiny lipid droplets. ACAT 
(CG8112) overexpression forms small lipid droplets and aberrant patch-like structures. 
Finally, knocking down SEIPIN in Drosophila S2 cells increased LD size, which was 
suppressed by knocking down GPAT simultaneously (Figure 5D). Together, these results 
strongly suggest that increased GPAT activity underpins the formation of supersized LDs in 
SEIPIN-deficient cells and tissues.
During Early Differentiation, SEIPIN Alters GPAT Kinetics
In addition to its role in modulating LD expansion, SEIPIN is required for normal 
adipogenesis. Loss of Seipin disrupts adipogenesis within the first few hours of 
differentiation (Chen et al., 2012; Payne et al., 2008). We asked whether this feature was 
also related to SEIPIN’s ability to regulate GPAT activity and PA metabolism. We first 
examined whether the level of PA is disturbed in Seipin knockdown 3T3-L1 preadipocytes 
by mass spectrometry. As shown in Figures 6A and 6B, total microsomal PA and the 
majority of PA species were significantly increased upon SEIPIN depletion. We then 
examined GPAT kinetics during the differentiation of 3T3L1 preadipocytes. In wild-type 
(WT) cells, the apparent KM values for glycerol-3-P after 0, 4, 8 and 12 hr of differentiation 
were 176, 267, 176, and 153 μM, respectively (Figure S6A), consistent with a transient drop 
in affinity for glycerol-3-P at 4 hr. In contrast, the apparent KM values for glycerol-3-P in 
Seipin knockdown cells at the same time points were 113, 147, 142, and 138 μM, 
respectively, values considerably lower than in the control cells (Figures S6B and S6C). 
These findings suggest the possibility that SEIPIN regulates GPAT kinetics early during 
differentiation to regulate PA homeostasis.
Increased GPAT3 Activity Impairs Adipogenesis in SEIPIN-Deficient Cells
If SEIPIN deficiency increases GPAT3 activity sufficiently to block adipogenesis, then 
reducing GPAT3 in SEIPIN-deficient cells should be able to restore adipogenesis. As 
predicted, in Seipin-deficient 3T3L1 preadipocytes, knocking down Gpat3, but not Gpat4, 
significantly enhanced adipocyte differentiation (Figures 6C, 6D, S6D, and S7A–S7E). 
Finally, to determine whether the increased GPAT activity is sufficient to block adipocyte 
differentiation, we overexpressed Gpat3 or Gpat4 in 3T3L1 preadipocytes. Overexpression 
of Gpat3 blocked adipogenesis (Figures S7F–S7H), whereas overexpressing Gpat4 had only 
a moderate inhibitory effect on adipogenesis (data not shown). Importantly, the simultaneous 
overexpression of Seipin and Gpat3 restored normal differentiation (Figure S7F–S7H). 
Taken together, these findings strongly support the interpretation that increased GPAT 
activity underlies the block in adipogenesis in Seipin-deficient cells.
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GPAT Inhibitor Partially Rescues the Differentiation of Seipin−/− Preadipocytes
Our results above strongly suggest that pharmacological inhibition of GPAT activity may 
also restore the differentiation of SEIPIN-deficient cells. Thus, we isolated primary 
preadipocytes from control and Seipin-deficient mice and differentiated them in the presence 
or absence of a GPAT inhibitor (formula: C21H26CINO4S) (Outlaw et al., 2014; Wydysh et 
al., 2009). The inhibition was competitive for NEM-sensitive (microsomal) and NEM-
resistant (mitochondrial) GPAT activities (Figure 7A). Inhibition of GPAT at 40 μM 
increased the number of cells positively stained with Oil red O, as well as the expression of 
adipogenesis marker genes in Seipin−/− cells (Figures 7B and 7C).
DISCUSSION
SEIPIN’s role in mammalian lipid storage is unique, because it regulates both adipocyte 
differentiation and the expansion of cellular LDs (Fei et al., 2011a). However, as an integral 
membrane protein of the ER without known functional domains, SEIPIN’s mechanism of 
action has been difficult to understand. Here, we demonstrate that SEIPIN and its yeast 
ortholog, Fld1, can interact specifically with the ER-located GPAT isoforms and that this 
evolutionarily conserved interaction diminishes the specific activity of both yeast and 
mammalian GPAT isoforms and alters their substrate affinities. Our data provide strong 
evidence that when SEIPIN is absent, enhanced microsomal GPAT activity results in 
defective adipogenesis and altered LD morphology.
The acylation of glycerol-3-P, catalyzed by GPAT, is the initial and rate-limiting step in the 
synthesis of triacylglycerol and the glycerophospholipids. The mitochondrial isoform 
GPAT1 contributes between 20% and 50% of the total GPAT activity in liver but only ~10% 
of total GPAT activity in other tissue types (Coleman and Mashek, 2011). A second 
mitochondrial GPAT isoform, GPAT2, is expressed primarily in testes. The microsomal 
GPAT isoforms, GPAT3 and GPAT4, have an 80% amino acid identity and, like the two Gat 
isoforms in yeast, are integral membrane proteins of the ER (Marr et al., 2012) but may 
move to the surface of LDs during LD expansion (Wilfling et al., 2013). Similarly, yeast 
Gat1 may be present on LDs during the stationary phase of yeast growth (Marr et al., 2012). 
Insulin increases the activities of mammalian GPAT3 and GPAT4 by phosphorylation at Ser 
and Thr residues, although the functional outcome of these modifications is unclear (Shan et 
al., 2010). Overall, the regulation of the ER GPATs remains largely unexplored, and no 
GPAT-interacting proteins have previously been identified.
Through a non-biased screen in yeast, we identified the yeast GPAT, Gat1, as a potential 
interacting partner of the yeast SEIPIN ortholog, Fld1. Multiple lines of evidence support a 
specific physical association between orthologs of SEIPIN and ER GPATs. Yeast and 
mammalian SEIPIN were co-immunoprecipitated with their respective yeast and 
mammalian GPAT orthologs, and both biotinylation and proximity ligation assays confirmed 
the close proximity of SEIPIN and GPAT3/4. Interestingly, compared to wild-type SEIPIN, 
the disease-causing missense mutant T78A had a weakened association with GPAT3/4. 
These data strongly support a specific physical association between SEIPIN and GPAT3/4. 
However, because both SEIPIN and the ER GPATs are integral membrane proteins that have 
resisted purification, we are unable to determine their stoichiometry in vitro or whether their 
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interaction is direct. Because SEIPIN forms oligomers (Sim et al., 2013; Binns et al., 2010; 
Fei et al., 2011b), it is possible that a single GPAT3/4 molecule may interact with a SEIPIN 
oligomer. Moreover, whether SEIPIN missense mutants such as T78A cause lipodystrophies 
through reduced interaction with GPAT remains inconclusive, and future studies will focus 
on this aspect.
The specific link between orthologs of SEIPIN and the ER GPAT isoforms was strongly and 
consistently supported by functional assays. SEIPIN deficiency is associated with two 
striking phenotypes: (1) a near complete block in adipogenesis and (2) the enlargement of 
LDs in yeast and in those mammalian cells and tissues in which SEIPIN is normally highly 
expressed, such as testes and mature adipocytes (Liu et al., 2014; Jiang et al., 2014). 
SEIPIN’s association with the ER GPAT isoforms can explain its roles in adipogenesis and 
LD expansion. As illustrated in Figure S8, our data support the hypothesis that when SEIPIN 
interacts with the ER GPATs, their enzymatic activity is reduced and the production of PA is 
diminished. Thus, the normal interaction of SEIPIN and the ER GPAT isoforms results in 
two major consequences: (1) because PA inhibits PPARγ, low GPAT activity during the first 
few hours of adipocyte differentiation permits PPARγ to be fully active, so that normal 
adipogenesis can proceed; and (2) in mature adipocytes, yeast, and other cells, SEIPIN-
regulated ER GPAT activity controls the size of LDs, possibly by limiting the amount of 
fusogenic PA (Figure S7). Conversely, in the absence of SEIPIN, ER GPAT-specific activity 
is enhanced and PA production increases. The high PA concentration may inhibit PPARγ 
activity or other signaling pathways in preadipocytes, thereby blocking adipogenesis 
(Stapleton et al., 2011; Zhang et al., 2012b; Nadra et al., 2012). In other cells, the absence of 
SEIPIN also results in high GPAT activity and increased local production of PA at the ER, 
resulting in aberrant LD budding and growth and the formation of supersized LDs (Fei et al., 
2011c). Several critical experiments support this interpretation, including the altered GPAT 
kinetics when SEIPIN is absent, the near-normal adipocyte differentiation that occurs when 
both SEIPIN and GPAT3 are absent, the formation of supersized LDs when the ER GPATs 
are overexpressed, and the reduction in LD size when SEIPIN and GPAT are co-expressed.
SEIPIN has been reported to interact with two other glycerolipid synthetic enzymes, 
AGPAT2 and LIPIN1 (Talukder et al., 2015; Sim et al., 2012). However, there is a 
fundamental difference between those studies and ours. SEIPIN was proposed to facilitate 
AGPAT2 and LIPIN1 function, whereas our data suggest that SEIPIN inhibits GPATs. 
Moreover, although the interaction of SEIPIN with AGPAT2 and LIPIN1 is relevant for the 
metabolism of PA, GPAT is recognized as the rate-limiting enzyme in the pathway. 
Importantly, the notion that SEIPIN anchors and facilitates LIPIN function overlooks 
existing physiological evidence (Talukder et al., 2015). For example, depleting lipin-1 in 
mouse adipocytes reduces the size of LDs, whereas depleting Seipin in mouse adipocytes 
increases LD size (Nadra et al., 2012; Liu et al., 2014). Furthermore, our co-
immunoprecipitation study in yeast could not detect a SEIPIN-LIPIN1 interaction (data not 
shown), and the yeast AGPAT2 homolog, Slc4, did not co-precipitate well with Fld1. 
Importantly, when overexpressed in the salivary gland of Drosophila under the same 
promoter, GPAT is the only enzyme that gave rise to supersized LDs.
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In Drosophila, SEIPIN has been reported to interact with sarco/endoplasmic reticulum 
calcium ATPase (SERCA), an ER-specific calcium pump (Bi et al., 2014). However, 
alterations in ER fatty acid and lipid composition are known to inhibit SERCA activity (Fu 
et al., 2011). Because our results support a primary function of SEIPIN in ER phospholipid 
metabolism, the disrupted calcium homeostasis observed in SEIPIN-deficient cells may be 
secondary to an altered ER phospholipid composition. Recent data also suggest that SEIPIN 
is involved in the vectorial export of TAG from the ER or the stabilization of ER-LD contact 
sites (Cartwright et al., 2015; Grippa et al., 2015). Our findings described here do not 
necessarily contradict with those observations; changes in PA concentration/localization of 
the ER may also impact the vectorial budding of droplets and/or the phospholipid 
composition of LDs (Wolinski et al., 2015; Han et al., 2015).
Although both GPAT3 and GPAT4 can interact with SEIPIN, they exhibited clear functional 
differences. Overexpressing either enzyme altered LD morphology at least in Huh7 cells, but 
only GPAT3 appeared to play a major role in adipogenesis (Shan et al., 2010). Surprisingly, 
although GPAT3 is highly upregulated in differentiating adipocytes, Gpat3−/− mice had 
relatively modest phenotypic alterations, and decreased weight gain was detected only when 
Gpat3−/− mice were fed a high-fat diet (Cao et al., 2014). GPAT4 is moderately upregulated 
during adipogenesis, but it is the major microsomal GPAT activity in brown adipose tissue, 
where its presence is required to limit the oxidation of exogenous fatty acids (Cooper et al., 
2015). Murine GPAT4 is known to localize to LDs (Wilfling et al., 2013); however, our data 
suggest that both ER GPATs can localize to LDs, particularly GPAT3.
Taken as a whole, our data provide strong evidence that SEIPIN interacts with and regulates 
ER GPATs in mammalian cells, fly, and S. cerevisiae. This is the first example of an 
evolutionarily conserved, physiological regulator of the ER GPATs.
EXPERIMENTAL PROCEDURES
Materials
Strains, primers, plasmids, and antibodies are listed in Tables S3–S7. [3H] Glycerol-3-P was 
synthesized enzymatically (Chang and Kennedy, 1967).
Isolation of Fld1-Interacting Proteins
Wild-type yeast cells transformed with plasmid pLacYCP-GFP and fld1Δ cells transformed 
with pLacYCP-Fld1-GFP were grown to early stationary phase and then lysed using a bead 
beater in three different buffers: buffer 1 (25 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5% 
Triton X-100, 0.2 mM EDTA, and 0.2 mM DTT), buffer 2 (20 mM K-HEPES [pH 7.4], 110 
mM CH3CO2K, 150 mM NaCl, 0.1% Triton X-100, 0.1% Tween 20, and 2 mM MgCl2), and 
buffer 3 (20 mM K-HEPES [pH 7.4], 110 mM CH3CO2K, 150 mM NaCl, 0.1% Triton 
X-100, 0.1% Tween 20, 46 mM n-octyl-B-D-glucopyranoside, 2 mM MgCl2, and 5% 
glycerol). Cell lysates were initially incubated with Sepharose CL-4B (GE Healthcare) to 
pull down proteins interacting with beads, and the supernatants were affinity purified using a 
GFP-Trap (ChromoTek) (Rothbauer et al., 2008) to pull down proteins interacting with GFP 
and Fld1-GFP, respectively.
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Identification of Fld1-Interacting Candidates
Proteins were eluted from Sepharose and GFP-Trap beads with a low-pH buffer (pH 2) 
containing 100 mM glycine, neutralized, and separated on 4%–15% Tris-HCl gels (Bio-
Rad). After staining with Coomassie brilliant blue R-250 (Sigma), protein bands were 
digested in-gel with trypsin (Shevchenko et al., 1996), and the sequences of the resultant 
peptides were determined by liquid chromatography tandem mass spectrometry using LTQ-
Orbi-trap Velos Pro (Thermo Fisher Scientific) coupled to UltiMate 3000 RSLC (Dionex). A 
list of candidate interactors was created from proteins identified in at least three Fld1-GFP 
pull-downs and absent in the controls (Table S1). Proteins were identified by at least two 
unique unmodified peptides with a score of −20.
Yeast Growth
Yeast cells were grown as described previously (Sherman, 2002).
Mammalian Cell Culture
HeLa, MEF, 3T3-L1, HEK293FT, and Phoenix Eco cells were grown in DMEM, 10% fetal 
bovine serum (FBS) (Invitrogen), and 100 U/mL penicillin and streptomycin. Cells were 
transiently transfected with plasmids using Lipofectamine LTX/Plus (Invitrogen). To induce 
triacylglycerol synthesis and LD formation, cells were incubated for 16 hr with 400 or 800 
μM BSA-coupled oleate.
Retro- and Lentivirus Production and Stable Cell Line Generation
pLKO.1-based shRNA lentiviral or pBABE-based retroviral expression constructs (Table 
S6) were used to generate lentivirus in HEK293T cells or retro-virus in Phoenix Eco cells, 
respectively. 3T3-L1 cells were incubated for 24 hr with lenti- or retrovirus together with 8 
μg/mL polybrene. Stable cells were selected with 4 μg/mL puromycin and/or 800 μg/mL 
neomycin for 10 days before use or storage in liquid N2.
Adipocyte culture and differentiation and qRT-PCR were carried out as described previously 
(Chen et al., 2012; Payne et al., 2008).
Pre-adipocyte Isolation and Differentiation
Animal protocols were approved by the University of North Carolina at Chapel Hill 
Institutional Animal Care and Use Committee. Mouse preadipocytes were isolated from 
gonadal adipose tissue. After excising blood vessels, adipose tissue was minced into small 
pieces, decanted into isolation medium (DMEM supplemented with 25 mM HEPES, 2% 
BSA, and 2 mg/mL collage-nase), and digested for 30 min at 37°C with constant shaking. 
Suspended cells were then filtered through a 100-μm nylon filter, centrifuged for 5 min at 
400 × g, and resuspended in DMEM supplemented with 10% newborn calf serum and 100 
U/mL penicillin and streptomycin. Differentiation was carried out as described above, and 
the GPAT inhibitor was present during the first 48 hr of differentiation.
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GPAT Activity and Kinetics
The right testis or MEFs and 3T3L1 cells from 10-cm dishes were homogenized in cold 
medium I (250 mM sucrose, 10 mM Tris [pH 7.4], 1 mM EDTA, 1 mM DTT) using 10 up-
and-down strokes with a Teflon-glass motor-driven homogenizer. Total membranes were 
isolated by centrifuging the homogenate at 100,000 × g for 1 hr. GPAT specific activity 
(initial rates) was assayed for 10 min at room temperature (RT) in a 200 μL reaction mixture 
containing 75 mM Tris-HCl (pH 7.5), 4 mM MgCl2, 1 mg/mL BSA (essentially fatty-acid-
free), 1 mM DTT, 8 mM NaF, 800 μM [3H]glycerol-3-P, and 82.5 μM palmitoyl-CoA. 
Membrane protein was incubated on ice for 15 min in the presence or absence of 2 mM 
NEM, which inactivates GPAT isoforms 2, 3, and 4 (Lewin et al., 2004). The reaction was 
initiated by adding 20 μg (testis), 15 μg (MEFs), or 5 μg (3T3L1) of membrane protein. 
Reaction products were extracted into 2 mL CHCl3. NEM-resistant activity (GPAT1) was 
calculated by subtracting NEM-sensitive activity from total activity. To determine the 
reaction products, 1 mL of the CHCl3 extract was dried under N2, resuspended in 30 μL 
CHCl3:CH3OH (2:1; v/v), and separated by thin-layer chromatography (CHCl3:pyridine:
88% formic acid, 50:30:7; v/v). More than 90% of the reaction product was PA, and the 
remainder was lysophosphatidic acid. [3H]Glycerol-3-P concentrations (40–400 μM) or 
palmitoyl-CoA concentrations (11.25–150 μM) were varied to analyze enzyme kinetics.
BY4741 and fld1Δ cells were collected by centrifuging at 3,000 × g for 5 min, rinsed twice 
in dH2O, and stored at −80°C until further use. To obtain total membrane fractions, yeast 
cells were resuspended in 1 mL zymolyase buffer (50 mM potassium phosphate [pH 7.5], 10 
mM β-mercaptoethanol) containing 1,000 U zymolyase (Zymo Research). Cell suspensions 
were shaken at 150 rpm at 30°C for 90 min. The supernatant was then homogenized, and 
membranes were isolated by centrifugation as described above. To assay GPAT activity in 
yeast, 20 μg membrane protein was pre-incubated in the presence of 50 μM 16:0 CoA for 1 
hr. Reactions were initiated by adding the [3H] glycerol-3-phosphate. To analyze enzyme 
kinetics in yeast, [3H] glycerol-3-P concentrations (5–400 μM) or palmitoyl-CoA 
concentrations (12.5–100 μM) were varied.
Co-immunoprecipitation and Western Blotting
Antibodies used are listed in Table S8. Yeast cell lysates were prepared as described 
previously (Fei et al., 2008). 2 mg protein was used for each co-immunoprecipitation 
condition. Antibody was immobilized on magnetic Dynabeads (Dynabeads Co-
Immunoprecipitation Kit manual). After 30 min of incubation with the cell lysates 
containing overexpressed protein at RT, or after overnight incubation with the cell lysates 
containing low levels of recombinant protein at 4°C, beads were washed and eluted at 37°C 
for 20 min. Proteins were transferred onto polyvinylidene fluoride (PVDF) membranes, 
followed by immunodetection (Fei et al., 2008).
Transiently or stably transfected mammalian cells (MEFs, mouse 3T3-L1preadipocytes, and 
HeLa cells) were washed three times with ice-cold PBS and lysed in immunoprecipitation 
(IP) lysis/wash buffer (as above) containing 1% (w/v) n-dodecyl-β-D-maltopyranoside 
(DDM; Sigma) by forcing the cells 30 times through a 0.8-mm needle. Immunoprecipitation 
and western blotting were carried out as described above.
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BirA* Pull-Down Assays
The cDNA for BirA* was subcloned from pGEM-SD2-BirA* (a kind gift of John 
Strouboulis, Erasmus University Medical Center, Rotterdam, the Netherlands). 3T3-L1 
preadipocytes were transduced with FLAG-tagged SEIPIN, FLAG-tagged biotin ligase 
BirA*, or FLAG-tagged BirA*-SEIPIN delivered using retrovirus, and cells were then 
induced to differentiate to mature adipocytes. On day 8 of differentiation, cells were treated 
with 50 μM biotin for 24 hr and then lysed. Cell lysates were precleared with empty protein 
G agarose beads for 4 hr and then incubated with streptavidin-conjugated agarose for 2 hr at 
room temperature. The beads were collected and washed with buffers as described 
previously (Roux et al., 2012), incubated with sample buffer containing 1.5 mM biotin, and 
heated for 1 hr at 65°C before western blot analysis.
Proximity Ligation Assay
HeLa cells transfected with indicated plasmids were fixed with 4% paraformaldehyde 
(Electron Microscopy Sciences) for 15 min and permeabilized with 0.2% Triton X-100 
(Sigma-Aldrich) for 10 min at room temperature. Cells were then blocked with 3% BSA in 
PBS for 1 hr and incubated with appropriate combinations of mouse anti-FLAG (1:100; 
Clontech Laboratories) and rabbit anti-HA (1:3,000; CST) antibodies diluted in blocking 
solution for 1 hr at room temperature. This was followed by proximity ligation assay using 
the Du-olink detection reagent kit (Olink Bioscience) according to the manufacturer’s 
protocol. Fluorescence images were acquired using an Olympus Fluoview FV1200 confocal 
microscope with a 60×/1.35 UPlanSApo objective. Images were prepared and analyzed with 
Fiji software (http://fiji.sc). For each experiment, signals from at least 50 cells were 
quantified. All data were analyzed using GraphPad PRISM software.
Fluorescence Microscopy
Yeast cells were stained with 20 μg/mL Nile red (Sigma-Aldrich). For mammalian lipid 
droplets, BODIPY 493/503 (Invitrogen) was used. Imaging was performed using a Leica 
SP5 confocal microscope and a Leica HCX 63× 1.4 numerical aperture objective.
Lipidomic Analysis of Microsomal PA
Phospholipids were extracted from microsomes isolated from yeast or mammalian cells, 
subjected to high performance liquid chromatography (HPLC) tandem mass spectrometry 
(MS/MS) and analyzed using Lipid Search software as described (Qi et al., 2016; Fei et al., 
2011c).
Drosophila experiments are as described previously (Tian et al., 2011). ppl-Gal4 was used to 
drive the overexpression of genes indicated.
Statistics
Experiments were performed in triplicate. The results are presented as mean ± SD. Two-
tailed Student’s t test was used for comparison.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Loss of SEIPIN function causes Berardinelli-Seip congenital lipodystrophy 2
• Lack of SEIPIN increases glycerol-3-phosphate acyltransferase (GPAT) 
activity
• Inhibiting GPAT enhances differentiation of SEIPIN-deficient preadipocytes
• Inhibiting GPAT corrects abnormal lipid droplet morphology in SEIPIN 
deficiency
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Figure 1. Fld1, Ldb16, and Gat1/2 Interact in Yeast
(A) Co-immunoprecipitation assay detecting the interaction between overexpressed Gat1-V5 
and Fld1-FLAG in yeast lysates.
(B) Gat1-V5 and Ldb16 of endogenous level co-immunoprecipitate with Fld1-FLAG.
(C) Using V5 antibody, overexpressed Fld1-FLAG co-immunoprecipitates with 
overexpressed Gat1-V5 and Gat2-V5 from wild-type and ldb16Δ yeast lysates.
See also Figure S1 and Table S1.
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Figure 2. Mammalian SEIPIN and GPAT3/4 Physically Interact
(A) Co-immunoprecipitation by FLAG and hemagglutinin (HA) antibody of overexpressed 
FLAG-tagged GPAT3 or GPAT4 and HA-tagged SEIPIN, respectively, from transfected 
MEF cell lysates.
(B and C) Immunoblotting for overexpressed HA-tagged mutant or wild-type SEIPIN and 
FLAG-tagged GPAT3 and GPAT4, respectively, after HA-immunoprecipitation from 3T3-L1 
cells. See also Figure S2.
(D) Endogenous GPAT4 and GPAT3 proteins co-immunoprecipitate with overexpressed 
SEIPIN from 3T3-L1 adipocytes stably transfected with HA- or FLAG-SEIPIN.
(E) 3T3-L1 adipocytes expressing FLAG-SEIPIN, FLAG-tagged biotin ligase BirA*, or 
FLAG-tagged BirA*-SEIPIN were treated with 50 μM biotin for 24 hr. The biotinylated 
proteins were pulled down using streptavidin-conjugated agarose from biological duplicates. 
Elutes were subjected to western blot analysis. All experiments were performed in triplicate.
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Figure 3. GPAT Activity Is Significantly Increased and GPAT Kinetics Are Altered in SEIPIN-
Deficient Cells and Tissues
(A–D) GPAT specific activity (initial rates) was measured in total membrane preparations 
from (A) BY4741 and fld1Δ yeast, (B) control and Bscl2−/− mouse embryonic fibroblasts, 
(C) control and shBSCL2 3T3L1 preadipocytes, and (D) control and Bscl2−/− testes. 
Membrane proteins were incubated on ice for 15 min in the presence or absence of 2 mM 
NEM. Experiments were performed in triplicate. Data are presented as mean ± SEM. See 
also Figure S3.
(E–H) GPAT dependence on glycerol-3-phosphate or Palmitoyl-CoA in control and Bscl2−/− 
testis (E and F) and control and shBSCL2 3T3-L1 preadipocytes (G and H). Glycerol-3-
phosphate and palmitoyl-CoA concentrations were varied as indicated. Double-reciprocal 
plots are shown in Figures S3G–S3J. All experiments were performed in triplicate. Data are 
presented as mean ± SEM.
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Figure 4. Increased GPAT Activity Underpins the Change in LD Morphology in SEIPIN-
Deficient Cells
(A) Nile-red-stained lipid droplets of BY4741 wild-type (WT), fld1Δ, GAT1-, or GAT2-
overexpressing strains (O/E Gat1 and O/E Gat2), strains over-expressing catalytically dead 
gat mutants (O/E Gat1 G262D and O/E Gat2 G253L), and double-transformed strains (O/E 
Gat1 + O/E Fld1 and O/E Gat2 + Fld1). The cells were grown to early stationary phase.
(B and E) Lipidomic analysis of microsomal PA in the indicated yeast strains and transduced 
pre-adipocytes. Phospholipids were extracted from cells, subjected to HPLC MS/MS, and 
analyzed using Lipid Search software. n = 4. *p < 0.05; **p < 0.01; ***p < 0.001.
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(C) BODIPY-stained lipid droplets in 3T3-L1 preadipocytes, transduced with indicated 
lentiviral expression vectors and incubated with 400 μM oleate for 16 hr. Representative 
confocal images are shown.
(D) Diameters of top three largest lipid droplets in 100 of each cell line were measured to 
determine the droplet volumes. Data represent mean ± SD (****p < 0.0001).
See also Figure S4.
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Figure 5. SEIPIN and GPAT Functionally Interact in Drosophila
(A–C) GPAT overexpression results in large lipid droplets similar to dSeipin mutants in the 
salivary gland of Drosophila. (A) Differential interference contrast (DIC) image of wild-type 
and dSeipin mutant larval salivary gland. Scale bar, 100 μm. (B) The largest lipid droplets in 
dSeipin mutants can be encircled by lipid droplet surface marker PLIN1-mCherry. The 
genotype is dSeipin; ppl-Gal4>UAS-PLIN1-mCherry. Scale bar, 50 μm. (C) DIC images of 
third-instar larval salivary gland of different genotypes. GPAT (Drosophila gene CG5508), 
AGPAT (CG17608), Lipin (CG8709), DGAT (CG31991), and ACAT (CG8112) were each 
overexpressed using the ppl-Gal4 promoter. Scale bar, 50 μm.
(D) RNAi-mediated knockdown of SEIPIN in Drosophila S2 cells increases LD size, which 
can be suppressed by simultaneously knocking down GPAT. Representative confocal images 
of RNAi-treated and BODIPY-stained cells are shown. Scale bar, 10 μm. Statistical testing 
utilized one-way ANOVA with a post-Tukey’s multiple comparison test. Error bars represent 
± SEM. ***p < 0.001.
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Figure 6. Increased GPAT3 Activity Impairs Adipogenesis in SEIPIN-Deficient Preadipocytes
(A and B) Lipidomic analysis of microsomal PA in control and shBSCL2 3T3L1 
preadipocytes. Phospholipids were extracted from cells, subjected to HPLC MS/MS, and 
analyzed using Lipid Search software. n = 4. *p < 0.05; **p < 0.01; ***p < 0.001.
(C) Oil red O stains of differentiated/undifferentiated 3T3-L1 cells stably transfected with 
the indicated lentiviral knockdown vectors.
(D) Pparγ, aP2 and C/ebpα mRNA levels were measured by qRT-PCR in 3T3-L1 cells 
transduced with the indicated lentiviral knockdown vectors at the indicated time points after 
induction of differentiation. All experiments were performed in triplicate. See also Figure 
S5.
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Figure 7. GPAT Inhibitor Can Partially Rescue the Differentiation of Seipin−/− Preadipocytes
(A) Glycerol-3-phosphate dependence of GPAT was determined by incubating 10–20 μg 
total particulate in the presence of 82.5 μM 16:0 CoA and varying the concentration of G3P 
from 10 to 800 μM, in the absence or presence of NEM. All experiments were performed in 
triplicates. Data are presented as mean ± SEM. See also Figure S6.
(B) The recovery of differentiation (day 8) is shown by Oil red O staining of WT, Bscl2 KO, 
and Bscl2 KO MEF cells treated with 40 μM inhibitor during the first 2 days of 
differentiation.
(C) Total RNA extracted from wild-type and Seipin−/− preadipocytes cultured in the 
presence or absence of GPAT inhibitor was used to measure the indicated mRNA levels by 
qPCR. Values represent mean ± SD of three independent experiments performed in 
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triplicate. Statistical analysis was performed using Student’s t test. *p < 0.05, inhibitor 
treatment versus DMSO in Seipin KO cells.
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